Endo PharmaceuticalsFrom Endo PharmaceuticalsFDA Tells Endo to Pull Opioid Opana ER From MarketFDA Says Opana’s Risks Outweigh BenefitsEndo Recalls Erectile Dysfunction Injection1.3 Million Birth Control Pills RecalledPage 1 of 1